Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Julia E.C. van Steenhoven"'
Autor:
Anne Kuijer, Paul J. van Diest, Robert Kornegoor, Thijs van Dalen, Gijs van Leeuwen, Julia E.C. van Steenhoven, Joost van Gorp
Publikováno v:
Histopathology
AIMS Phosphohistone H3 (PhH3) has been proposed as a novel proliferation marker in breast cancer. This study compares the interobserver agreement for assessment of the mitotic activity index (MAI), Ki67 expression, and PhH3 in a cohort of oestrogen r
Autor:
Bianca M den Dekker, Thijs van Dalen, Paul J. van Diest, Julia E.C. van Steenhoven, Anne Kuijer, Sabine Siesling, Sjoerd G. Elias
Publikováno v:
Cancer Research. 80:P2-14
Background: Early stage breast cancer patients are often confronted with uncertainty regarding the decision to undergo adjuvant chemotherapy (CT). Gene-expression profiles (GEP) are used to gain additional prognostic information and can influence adj
Autor:
Julia E.C. van Steenhoven, Thijs van Dalen, Anne Kuijer, Liesbeth J. Boersma, Sabine Siesling, Marjolein L. Smidt, Marleen M. Roos, Marissa C. van Maaren, Sjoerd G. Elias, Paul J. van Diest
Publikováno v:
Annals of surgical oncology, 27(9), 3402-3411. Springer
Annals of Surgical Oncology
Annals of Surgical Oncology, 27(9), 3402-3411. Springer, Cham
Annals of Surgical Oncology
Annals of Surgical Oncology, 27(9), 3402-3411. Springer, Cham
Background Despite the potential for residual lymph node metastases after a negative or positive sentinel lymph node biopsy (SLNB), breast cancer patients rarely experience regional recurrences (RRs). This study aimed to quantify the effects of nonsu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac6d64012d10bc9385ad4420f2a48fb
https://research.utwente.nl/en/publications/9187f569-31f2-4615-b93d-81fa515f72a2
https://research.utwente.nl/en/publications/9187f569-31f2-4615-b93d-81fa515f72a2
Autor:
Julia E.C. van Steenhoven, Marloes A Smit, Wilma E. Mesker, Thijs van Dalen, Rob A. E. M. Tollenaar, Paul J. van Diest
Publikováno v:
Journal of Surgery and Research, 3(2), 112-118. Fortune Journals
Background: Strategies for breast cancer care are improving. However, there is a clinical need for a better selection of patients who are at risk for recurrence and benefit from treatment with chemotherapy. The 70-gene signature (70-GS) guides chemot
Publikováno v:
Annals of Surgical Oncology
Autor:
Marleen M. Roos, Thijs van Dalen, Sjoerd G. Elias, Kim C. Aalders, K. Schreuder, Sabine Siesling, Julia E.C. van Steenhoven, J. P. J. Burgmans
Publikováno v:
Annals of Surgical Oncology, 26(2), 372. Springer New York
Annals of surgical oncology, 26(2), 372-378. Springer
Annals of surgical oncology, 26(2), 372-378. Springer
Background: Although the false-negative rate of the sentinel lymph node biopsy (SLNB) in breast cancer patients is 5–7%, reported regional recurrence (RR) rates after negative SLNB are much lower. Adjuvant treatment modalities probably contribute t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a7b0e47086733c50dc1070c078f77db
https://dspace.library.uu.nl/handle/1874/377151
https://dspace.library.uu.nl/handle/1874/377151
Autor:
Joost van Gorp, Paul J. van Diest, Thijs van Dalen, A. van Leeuwen, Julia E.C. van Steenhoven, Anne Kuijer
Publikováno v:
Cancer Research. 80:P5-02
Introduction: Determining expression of tumor proliferation by mitotic index or Ki67 expression is one of the strongest prognostic factors in breast cancer, but its reproducibility is not optimal. Recently, phosphohistone H3 (PHH3) was proposed as a
Autor:
Sjoerd G. Elias, Thijs van Dalen, Emiel J. Th. Rutgers, Anne Kuijer, Joost van Gorp, Marieke E. Straver, Johanna N. H. Timmer-Bonte, Sabine Siesling, Tineke J. Smilde, Jelle Wesseling, Julia E.C. van Steenhoven, Charlotte F.J.M. Blanken, Paul J. van Diest, Alex L.T. Imholz, Peter Nieboer
Publikováno v:
Genes, 9, 5
Genes
Genes, 9(5). Multidisciplinary Digital Publishing Institute (MDPI)
Genes, 9(5):261. MDPI
Genes; Volume 9; Issue 5; Pages: 261
Genes, 9
Genes
Genes, 9(5). Multidisciplinary Digital Publishing Institute (MDPI)
Genes, 9(5):261. MDPI
Genes; Volume 9; Issue 5; Pages: 261
Genes, 9
In this study, in estrogen receptor positive (ER+) early stage breast cancer patients who were considered candidates for 70-gene signature (70-GS, “MammaPrint”) use, we compared molecular subtyping (MS) based on the previously validated 80-gene s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91edc345dbbc4760cadbc9b4c69d841d
https://doi.org/10.3390/genes9050261
https://doi.org/10.3390/genes9050261
Publikováno v:
Annals of Surgical Oncology
Autor:
Sabine Siesling, T.V. Dalen, Anne Kuijer, Paul J. van Diest, S. G. Elias, Elsken van der Wall, Julia E.C. van Steenhoven, K. Schreuder
Publikováno v:
Annals of Oncology. 30:iii30